- Home
- MAX vs RLAY Comparison
MAX vs RLAY Comparison
Compare MAX & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAX
- RLAY
- Stock Information
- Founded
- MAX 2014
- RLAY 2015
- Country
- MAX United States
- RLAY United States
- Employees
- MAX N/A
- RLAY N/A
- Industry
- MAX Industrial Machinery/Components
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MAX Industrials
- RLAY Health Care
- Exchange
- MAX Nasdaq
- RLAY Nasdaq
- Market Cap
- MAX 613.7M
- RLAY 723.1M
- IPO Year
- MAX 2020
- RLAY 2020
- Fundamental
- Price
- MAX $11.24
- RLAY $4.66
- Analyst Decision
- MAX Buy
- RLAY Strong Buy
- Analyst Count
- MAX 8
- RLAY 10
- Target Price
- MAX $22.00
- RLAY $20.11
- AVG Volume (30 Days)
- MAX 460.9K
- RLAY 2.9M
- Earning Date
- MAX 02-18-2025
- RLAY 02-20-2025
- Dividend Yield
- MAX N/A
- RLAY N/A
- EPS Growth
- MAX N/A
- RLAY N/A
- EPS
- MAX 0.19
- RLAY N/A
- Revenue
- MAX $681,230,000.00
- RLAY $10,006,000.00
- Revenue This Year
- MAX $124.41
- RLAY N/A
- Revenue Next Year
- MAX $31.11
- RLAY N/A
- P/E Ratio
- MAX $59.54
- RLAY N/A
- Revenue Growth
- MAX 72.47
- RLAY N/A
- 52 Week Low
- MAX $10.21
- RLAY $3.50
- 52 Week High
- MAX $25.78
- RLAY $11.16
- Technical
- Relative Strength Index (RSI)
- MAX 46.70
- RLAY 52.22
- Support Level
- MAX $11.02
- RLAY $3.50
- Resistance Level
- MAX $11.45
- RLAY $5.99
- Average True Range (ATR)
- MAX 0.45
- RLAY 0.54
- MACD
- MAX 0.08
- RLAY 0.04
- Stochastic Oscillator
- MAX 59.63
- RLAY 46.59
About MAX MediaAlpha Inc.
MediaAlpha Inc provides a platform that facilitates insurance carriers and distributors target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It acts as a customer acquisition channel in the areas of property & casualty insurance, health insurance, and life insurance. It operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).